Biocept director just picked up 90,909 shares

David F Hale, a director of Biocept, recently acquired 90,909 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from June 16 to October 19, 2016. Hale now owns 168,553 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Hale operates out of San Diego, CA. Some additional info was provided as follows:

As adjusted for the 1-for-3 reverse stock split effected September 27, 2016. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 36,380 fewer shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 33,468 fewer shares. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 85,434 fewer shares.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Jan. 11, 2017

Auto Refresh

Feedback